*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Ticagrelor is a potent, reversible <strong>P2Y12 receptor antagonist</strong> used in cardiovascular therapy. Synthesized via advanced organic catalysis, its molecular formula is <strong>C23H28F3N3O4S</strong> with CAS No. 466707-15-3.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical Manufacturing:</strong> Active Pharmaceutical Ingredient (API) for antiplatelet tablets.</li>
<li><strong>Cardiovascular Treatment:</strong> Management of Acute Coronary Syndrome (ACS) to prevent thrombotic events.</li>
<li><strong>Post-PCI Care:</strong> Adjunct therapy following percutaneous coronary intervention.</li>
</ul>
<h3>Precautions</h3>
<p>Contraindicated in patients with active bleeding or history of intracranial hemorrhage. Store API at controlled room temperature (20°C–25°C) in dry, sealed containers to maintain stability and potency.</p>